|

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

RECRUITINGPhase 2Sponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhasePhase 2
SponsorM.D. Anderson Cancer Center
Started2020-08-24
Est. completion2026-12-31
Eligibility
Healthy vol.Accepted
Locations1 site

Summary

This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
* PATIENT: 18 years or older
* PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
* PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
* PATIENT: Able to read and understand English as assessed by the treating physician
* CAREGIVER: Identified or self-identified as primary caregiver of the patient
* CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
* CAREGIVER: 18 years or older
* CAREGIVER: Able to read and understand English as assessed by the treating physician
* ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
* ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)

Exclusion Criteria:

* Unable to understand and sign consent

Conditions3

Advanced Malignant Solid NeoplasmCancerHematopoietic and Lymphoid Cell Neoplasm

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Sriram Yennu713-792-6085

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.